HER2+ and ER+ Metastatic Breast Cancer: Clinical Applications of the Latest Data

Title:

HER2+ and ER+ Metastatic Breast Cancer: Clinical Applications of the Latest Data

Topic: Oncology/ Hematology
Relevant Terms: Breast Cancer, Metastatic Breast Cancer
Primary Audience: Oncologists and other health care professionals who treat and care for patients with breast cancer.
Launch Date: 29-May-14
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Evaluate emerging clinical trial evidence in HER2-positive and ER-positive metastatic breast cancer (MBC)
  2. Identify the most appropriate treatment options for patients with HER2-positive and ER-positive MBC

    Faculty

    Kimberly L. Blackwell, MD
    Professor of Medicine
    Duke University
    Sara A. Hurvitz, MD
    Assistant Clinical Professor
    UCLA School of Medicine
    Director, Breast Oncology Program
    UCLA Jonsson Comprehensive Cancer Center
    Los Angeles, CA
    Ruth M. O'Regan, MD
    Professor
    Emory University
    Atlanta, GA
    Instructions on How to Receive Credit
    • Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
    • Complete the post-test and evaluation.
    • After passing the post-test, print out your electronic CE certificate.
    • In order to successfully complete this activity learners must achieve a minimum of 65% on the post-test.
     
    Sponsored by the Institute for Continuing Healthcare Education.
     
    Supported by an educational grant from Novartis.
     
    Accreditation Statements
    Physicians
    The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    The Institute for Continuing Healthcare Education designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
     
    Disclosure
    It is the policy of the Institute to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All persons in control of content must disclose any significant financial interest or other relationships that may affect the content of this activity.

    Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.
     
    Faculty
    Kimberly Blackwell, MD
    Professor of Medicine
    Duke University Medical Center
    Durham, NC
     
    Dr. Blackwell has disclosed the following relevant financial relationships that have occurred within the past 12 months: Amgen, Roche/A; Celgene, Genentech, Novartis, /C; Celgene, Genentech, Pfizer/G.
     
    Sara A. Hurvitz, MD
    Assistant Professor of Medicine
    UCLA Hematology-Oncology
    Los Angeles, CA
     
    Dr. Hurvitz has disclosed the following relevant financial relationships that have occurred within the past 12 months: Amgen, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Novartis, OBI Pharma, Pfizer, PUMA, Roche and Sanofi/G; Boehringer Ingelheim, Genentech, Roche/O.
     
    Ruth O’Regan, MD
    Director of Translational Breast Cancer Research
    The Winship Cancer Institute
    Emory University
    Atlanta, GA
     
    Dr. O’Regan has disclosed the following relevant financial relationships that have occurred within the past 12 month: Novartis/A,G; Roche/C,G.
     
    Freelance Medical Writer
    Kate Evans has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
     
    Peer Reviewer
    Eleni Andreopolou, MD, has disclosed that she has no relevant financial relationships specific to the subject matter of this activity that have occurred within the past 12 months. 
     
    Activity Development & Management Team
    Cathy Pagano, CCMEP; Scott Kober, MBA, CCMEP; Sandra Davidson; and Megan Small; are employees of the Institute and are collectively responsible for the planning, development, and management of this CME activity. These individuals have disclosed that they have had no relevant financial relation­ships specific to the subject matter of this activity that have occurred within the past 12 months.
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 5.0+ for Mac OSX 10.5 and above

    For video playback, install the latest version of Flash or Quicktime.
     
    For additional technical support, please send an email to msmall@iche.edu.
     
    General Disclosure and Copyright Statement
    The opinions expressed in this publication are those of the participating faculty and not those of the Institute, Novartis, or any manufacturers of products mentioned herein.
     
    This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.
     
    Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.
     
    Copyright 2014. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.
     
    The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.